118 related articles for article (PubMed ID: 38326205)
21. A comprehensive investigation of nutritional status and psoas muscle mass in predicting five-year survival in patients with liver transplant.
Tsao YT; Lee WC; Huang CH; Lin IH; Huang YY
J Formos Med Assoc; 2022 Jul; 121(7):1317-1324. PubMed ID: 34666924
[TBL] [Abstract][Full Text] [Related]
22. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
Kim SH; Lee EC; Na BG; Park SJ
Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
Hu Z; Qian Z; Wu J; Zhou J; Zhang M; Zhou L; Zheng S
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):315-326. PubMed ID: 26382281
[TBL] [Abstract][Full Text] [Related]
24. Preoperative low muscle mass has a strong negative effect on pulmonary function in patients undergoing living donor liver transplantation.
Shirai H; Kaido T; Hamaguchi Y; Yao S; Kobayashi A; Okumura S; Kamo N; Yagi S; Okajima H; Uemoto S
Nutrition; 2018 Jan; 45():1-10. PubMed ID: 29129228
[TBL] [Abstract][Full Text] [Related]
25. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation.
Hamaguchi Y; Kaido T; Okumura S; Fujimoto Y; Ogawa K; Mori A; Hammad A; Tamai Y; Inagaki N; Uemoto S
Liver Transpl; 2014 Nov; 20(11):1413-9. PubMed ID: 25088484
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Impact of Osteopenia in Patients Who Underwent Living Donor Liver Transplantation for Hepatocellular Carcinoma.
Toshima T; Yoshizumi T; Kosai-Fujimoto Y; Inokuchi S; Yoshiya S; Takeishi K; Itoh S; Harada N; Ikegami T; Soejima Y; Mori M
World J Surg; 2020 Jan; 44(1):258-267. PubMed ID: 31624895
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
Lei J; Yan L; Wang W
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
[TBL] [Abstract][Full Text] [Related]
28. Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation.
Harada N; Shirabe K; Ikeda Y; Korenaga D; Takenaka K; Maehara Y
Ann Transplant; 2012 Dec; 17(4):11-20. PubMed ID: 23274319
[TBL] [Abstract][Full Text] [Related]
29. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
[TBL] [Abstract][Full Text] [Related]
30. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
[TBL] [Abstract][Full Text] [Related]
31. Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria.
Jiang L; Yan LN; Wen TF; Li B; Yang JY
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):494-9. PubMed ID: 24103279
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
Rajakannu M; Vij M; Shaikh TMA; Rammohan A; Reddy MS; Rela M
Indian J Gastroenterol; 2021 Feb; 40(1):30-34. PubMed ID: 33548018
[TBL] [Abstract][Full Text] [Related]
33. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
[TBL] [Abstract][Full Text] [Related]
34. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation.
Di Sandro S; Slim AO; Giacomoni A; Lauterio A; Mangoni I; Aseni P; Pirotta V; Aldumour A; Mihaylov P; De Carlis L
Transplant Proc; 2009 May; 41(4):1283-5. PubMed ID: 19460539
[TBL] [Abstract][Full Text] [Related]
35. The long-term outcomes of patients with hepatocellular carcinoma after living donor liver transplantation: a comparison of right and left lobe grafts.
Taketomi A; Shirabe K; Toshima T; Morita K; Hashimoto N; Kayashima H; Ikegami T; Yoshizumi T; Soejima Y; Maehara Y
Surg Today; 2012 Jun; 42(6):559-64. PubMed ID: 22245925
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma.
Abe T; Tashiro H; Teraoka Y; Hattori M; Tanimine N; Kuroda S; Tahara H; Ohira M; Tanaka Y; Kobayashi T; Ide K; Ishiyama K; Ohdan H
Dig Surg; 2016; 33(1):8-14. PubMed ID: 26551258
[TBL] [Abstract][Full Text] [Related]
37. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
38. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
Azoulay D; Audureau E; Bhangui P; Belghiti J; Boillot O; Andreani P; Castaing D; Cherqui D; Irtan S; Calmus Y; Chazouillères O; Soubrane O; Luciani A; Feray C
Ann Surg; 2017 Dec; 266(6):1035-1044. PubMed ID: 27617853
[TBL] [Abstract][Full Text] [Related]
39. Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.
Itoh S; Yoshizumi T; Kimura K; Okabe H; Harimoto N; Ikegami T; Uchiyama H; Shirabe K; Nishie A; Maehara Y
Anticancer Res; 2016 Jun; 36(6):3029-34. PubMed ID: 27272822
[TBL] [Abstract][Full Text] [Related]
40. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma.
Takada Y; Ueda M; Ito T; Sakamoto S; Haga H; Maetani Y; Ogawa K; Kasahara M; Oike F; Egawa H; Tanaka K
Liver Transpl; 2006 Jun; 12(6):912-9. PubMed ID: 16489583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
